A systematic review and meta-analysis of macrolides in the management of adult patients with asthma
Allergology International · 2024
DOI: 10.1016/j.alit.2024.01.002 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Allergology International, 2024. Verfasst von Hiroshi Ohnishi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine and Allergology, Kochi Medical School, Kochi University, Kochi, Japan. Electronic address: honi@kochi-u.ac.jp. Hauptthemen laut MEDLINE: Anti-Asthmatic Agents, Asthma, Macrolides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: The efficacy of macrolides in the management of asthma has been studied but remains controversial. We conducted a systematic review and meta-analysis of macrolides in the management of adult patients with asthma. METHODS: Randomized controlled trials of macrolides used in adult patients with asthma were searched for in MEDLINE, EMBASE, PsycINFO, Cochrane Library, CINAHL, and Igaku Chuo Zasshi databases to evaluate the efficacy and safety of macrolides. RESULTS: Seventeen reports with macrolide treatment durations ranging from 6 to 48 weeks were included. Macrolides did not reduce exacerbations requiring hospitalization, severe exacerbations, or rescue use of short-acting beta-2 agonist inhalers; improve lung function; decrease peripheral blood or sputum neutrophil counts; or decrease fractional exhaled nitric oxide compared to placebo. Macrolides statistically improved asthma control and quality of life but by less than the minimal clinically important difference. Peripheral blood eosinophil counts as well as serum and sputum eosinophilic cationic protein concentrations were significantly decreased with macrolides compared to placebo. The improvement of asthma symptoms and airway hyperresponsiveness varied by study. The safety profile of macrolides was comparable to that of placebo. CONCLUSIONS: Although macrolides have some useful clinical aspects, there is not sufficient evidence to recommend their use in the management of adult patients with asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine and Allergology, Kochi Medical School, Kochi University, Kochi, Japan. Electronic address: honi@kochi-u.ac.jp.
- Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
- Department of Respiratory Medicine, Allergy, and Clinical Immunology, Nagoya City University of Medical Sciences, Nagoya, Japan.
- Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
- Department of Respiratory Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
- Department of Environmental Medicine, Kochi Medical School, Kochi University, Kochi, Japan.
Zitieren
APA
Ohnishi, H., Otani, T., Kanemitsu, Y., Nagano, T., Hara, J., & Eitoku, M. (2024). A systematic review and meta-analysis of macrolides in the management of adult patients with asthma. Allergology International. https://doi.org/10.1016/j.alit.2024.01.002
Vancouver
Ohnishi H, Otani T, Kanemitsu Y, Nagano T, Hara J, Eitoku M. A systematic review and meta-analysis of macrolides in the management of adult patients with asthma. Allergology International. 2024. doi:10.1016/j.alit.2024.01.002
BibTeX
@article{Ohnishi2024,
author = {Ohnishi, Hiroshi and Otani, Toshihito and Kanemitsu, Yoshihiro and Nagano, Tatsuya and Hara, Johsuke and Eitoku, Masamitsu},
title = {A systematic review and meta-analysis of macrolides in the management of adult patients with asthma},
journal = {Allergology International},
year = {2024},
doi = {10.1016/j.alit.2024.01.002}
}
EUVIMED